MedPath

Vabicaserin

Generic Name
Vabicaserin
Drug Type
Small Molecule
Chemical Formula
C15H20N2
CAS Number
887258-95-9
Unique Ingredient Identifier
WD9550HPNL

Overview

Vabicaserin has been used in trials studying the health services research and treatment of Schizophrenia.

Background

Vabicaserin has been used in trials studying the health services research and treatment of Schizophrenia.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Comparative Formulation Study of Vabicaserin
Phase 1
Completed
Posted: 2009/06/26
Sponsor:
Wyeth is now a wholl...
ID:NCT00928551
Study Evaluating Vabicaserin in Subjects With Schizophrenia
Phase 2
Completed
Posted: 2007/11/26
Sponsor:Pfizer
ID:NCT00563706
Study Comparing Bioavailability of Oral Formulations of Vabicaserin
Phase 1
Completed
Posted: 2007/10/10
Sponsor:
Wyeth is now a wholl...
ID:NCT00541996
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects
Phase 1
Completed
Posted: 2007/07/25
Sponsor:
Wyeth is now a wholl...
ID:NCT00505973
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects
Phase 1
Completed
Posted: 2007/04/09
Sponsor:
Wyeth is now a wholl...
ID:NCT00458107

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy